4.4 Article

Treatment advances in gout

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.berh.2021.101719

关键词

Gout; Treatment; Urate lowering; Flares

资金

  1. Canterbury Arthritis Support Trust
  2. Bannan bequest administered via the Foundation Trust University of Otago

向作者/读者索取更多资源

The purpose of gout treatment is to alleviate symptoms of flares, prevent flares from recurring by lowering serum urate, and minimize structural joint damage and functional impairment. Despite the availability of multiple effective therapies, suboptimal management and outcomes are often due to under-prescribing of urate-lowering therapy by physicians and poor adherence with prescribed therapy by patients.
The purpose of gout treatment is to alleviate symptoms of flares, prevent flares from recurring by lowering serum urate, and mini-mize structural joint damage and functional impairment. In recent years, several new medications to treat gout have been developed, and novel agents continue to be investigated, in addition to several long-established treatments. Although a number of effective therapies are available, optimal management and outcomes are frequently not achieved due to physician under prescribing of urate-lowering therapy (ULT) and poor adherence with therapy when it is prescribed. This article reviews recent developments in the management of gout with reference to recently published clinical guidelines, outlines some important questions regarding the safety and efficacy of particular agents, and remaining gaps in our knowledge about the most effective strategies for using currently available treatments. (c) 2021 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据